A detailed history of Altium Capital Management LP transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 811,167 shares of SPRB stock, worth $356,913. This represents 0.22% of its overall portfolio holdings.

Number of Shares
811,167
Previous 1,150,000 29.46%
Holding current value
$356,913
Previous $908,000 53.63%
% of portfolio
0.22%
Previous 0.51%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.51 - $0.85 $172,804 - $288,008
-338,833 Reduced 29.46%
811,167 $421,000
Q1 2024

May 15, 2024

BUY
$0.7 - $5.49 $805,000 - $6.31 Million
1,150,000 New
1,150,000 $908,000

Others Institutions Holding SPRB

About SPRUCE BIOSCIENCES, INC.


  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $10.4M
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.